PT  - JOURNAL ARTICLE
AU  - Ferrucci, Pier Francesco
AU  - Di Giacomo, Anna Maria
AU  - Del Vecchio, Michele
AU  - Atkinson, Victoria
AU  - Schmidt, Henrik
AU  - Schachter, Jacob
AU  - Queirolo, Paola
AU  - Long, Georgina V
AU  - Stephens, Rosalie
AU  - Svane, Inge Marie
AU  - Lotem, Michal
AU  - Abu-Amna, Mahmoud
AU  - Gasal, Eduard
AU  - Ghori, Razi
AU  - Diede, Scott J
AU  - Croydon, Elizabeth S
AU  - Ribas, Antoni
AU  - Ascierto, Paolo Antonio
ED  - ,
TI  - KEYNOTE-022 part 3: a randomized, double-blind, phase 2 study of pembrolizumab, dabrafenib, and trametinib in <em>BRAF</em>-mutant melanoma
AID  - 10.1136/jitc-2020-001806
DP  - 2020 Dec 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e001806
VI  - 8
IP  - 2
4099  - http://jitc.bmj.com/content/8/2/e001806.short
4100  - http://jitc.bmj.com/content/8/2/e001806.full
SO  - J Immunother Cancer2020 Dec 01; 8
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.